Stanford Medicine News
Precision Health
Read about Stanford Medicine's vision for leading the biomedical revolution.
-
COVID-19-Research
A curated list of Stanford Medicine research projects to prevent, diagnose and treat COVID-19, as well as to understand how it spreads and how people’s immune systems respond to it.
-
Antiviral treatments lead researchers to develop possible cancer drug
An effort to thwart viral diseases like hepatitis or the common cold led to a new collaboration and a novel class of cancer drugs that appears effective in mice.
-
A new view on brain surgery
Guided by lasers, fluorescence and real-time imaging, Stanford surgeons develop new ways to enhance precision.
-
Suspicion: Why are virus-targeting immune cells sniffing around Alzheimer’s patients’ brains?
In a new study published in Nature, Stanford neuroscientist Tony Wyss-Coray, PhD, and his colleagues report the startling discovery of virus-obsessed immune cells in autopsied brains of deceased Alzheimer's patients, and in cerebrospinal fluid (which bathes our brains) of living individuals diagnosed with the disease.
-
Stanford researchers program cancer-fighting cells to resist exhaustion, attack solid tumors in mice
CAR-T cells are remarkably effective against blood cancers, but their effect can be transient as the cells become exhausted. Stanford researchers found a way to keep the cells effective in mice with human tumors.
-
Big data conference focuses on technologys role in health care
Dozens of speakers gathered at Stanford to discuss health, artificial intelligence and evolving technology and how it all could affect patient care at the annual Big Data in Precision Health conference.
-
Pride study of LGBTQ health now based at Stanford
The study is collecting demographic and health information from participants who identify as lesbian, gay, bisexual, transgender or queer, as well as suggestions for the health topics to be studied.
-
Biomarker for chronic fatigue syndrome identified
Stanford scientists devised a blood-based test that accurately identified people with chronic fatigue syndrome, a new study reports.
-
Stanford Medicine pilot program for precision health
A Stanford clinical trial that provided proactive, personalized care to participants detected overlooked health conditions and risks.
-
Researchers develop urine test for bladder cancer
Two researchers at the School of Medicine have developed a highly sensitive urine test for more easily diagnosing and monitoring bladder cancer, the sixth most common cancer.
-
Brain implant lets people with limb paralysis compose and send emails select videos and even play music just by thinking
New clinical trial results show that people with paralysis who have been equipped with a technologically advanced, baby-aspirin-sized brain implant can learn to directly operate an off-the-shelf computer tablet, just by thinking.
-
Stanford engineers and medical researchers create wireless, battery-free, biodegradable blood flow sensor
The first-of-its-kind sensor measures the flow of blood through an artery and can warn a patient’s doctor remotely if there is a blockage, making it easier for doctors to monitor the success of blood vessel surgery.
-
Steven Artandi tapped to lead stanford cancer institute
Steven Artandi, MD, PhD, the Jerome and Daisy Low Gilbert Professor and professor of medicine and biochemistry, was recently named the new director of the Stanford Cancer Institute.
-
Stanford Children’s Health appoints new president and CEO
Paul King has been selected as the new president and CEO of Lucile Packard Children’s Hospital Stanford and Stanford Children’s Health.
-
Progress, priorities, challenges are focus of State of Stanford Medicine
At this year’s State of Stanford Medicine event, the dean, hospital CEOs and a special guest shared their reflections on the strengths and challenges of the medical center today.
-
Technologies started at Stanford Biodesign have reached more than 1.5 million patients
Stanford Biodesign trainees have developed new medical devices and diagnostics that have been used to help care for more than 1.5 million patients so far.
-
Researchers can forecast risk of deadly vascular condition from genome sequence
By combining genome-sequence information and health records, Stanford scientists have developed a new algorithm that can predict the risk of abdominal aortic aneurysm, and potentially could be used for any number of diseases.
-
‘Liquid biopsy’ predicts lymphoma therapy success within days
Changes in circulating tumor DNA levels quickly predict how patients with diffuse large B cell lymphoma are responding to therapy, according to a Stanford-led study. Currently, patients wait months for the results.
-
Solar-powered heart: Stanford scientists explore using photosynthesis to help damaged hearts
In the ongoing hunt to find better treatments for heart disease, the top cause of death globally, new research from Stanford shows promising results using an unusual strategy: photosynthetic bacteria and light.
-
Researchers identify biomarkers associated with chronic fatigue syndrome severity
Stanford investigators used high-throughput analysis to link inflammation to chronic fatigue syndrome, a difficult-to-diagnose disease with no known cure.
